MHI-null mice developed tumors with a short latency (3.95 months), while mice heterozygous for the Cdkn2a locus (MHI-het) showed delayed tumor formation (6 months) (Figure 3—figure supplement 1C). Here, CDKN2A is linked to neoplasm.